Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential

[1]  A. Petherick.  Developing antibody tests for SARS-CoV-2 , 2020, The Lancet.

[2]  J. Nkengasong,et al.  Looming threat of COVID-19 infection in Africa: act collectively, and fast , 2020, The Lancet.

[3]  J. Nkengasong.  China’s response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response , 2020, Nature Medicine.

[4]  Victor M Corman,et al.  Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  R. Peeling,et al.  Epidemic preparedness: why is there a need to accelerate the development of diagnostics? , 2019, The Lancet. Infectious diseases.

[6]  R. Peeling,et al.  Importance of diagnostics in epidemic and pandemic preparedness , 2019, BMJ Global Health.

[7]  R. Peeling,et al.  ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the Americas , 2019, Global health action.

[8]  R. Peeling,et al.  ZikaPLAN: Zika Preparedness Latin American Network , 2017, Global health action.

[9]  H. Margolis,et al.  Evaluation of Commercially Available Diagnostic Tests for the Detection of Dengue Virus NS1 Antigen and Anti-Dengue Virus IgM Antibody , 2014, PLoS Neglected Tropical Diseases.

[10]  Matthias Buck,et al.  The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization to the Convention on Biological Diversity , 2011 .

[11]  R. Peeling,et al.  The TDR Tuberculosis Specimen Bank: a resource for diagnostic test developers. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[12]  R. Peeling,et al.  Visceral Leishmaniasis Rapid Diagnostic Test Performance , 2011 .